Overview

Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy

Status:
Terminated
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness and safety of the drug GSK189254 in treating patients with narcolepsy.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Histamine
Histamine H3 Antagonists